{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:04Z","timestamp":1786984264288,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Human immunodeficiency virus (HIV) infection causes gut epithelial barrier dysfunction and dyslipidemia. Intestinal fatty acid-binding protein (I-FABP) and regenerating islet-derived protein 3 alpha (REG3\u03b1) are markers of gut barrier integrity. We investigated the association between these biomarkers and LDL-cholesterol (LDL-C) in HIV-infected individuals, stratified by immune status and disease duration. This cross-sectional study included 69 HIV-infected adults on antiretroviral therapy. Plasma I-FABP, REG3\u03b1, and lipid parameters were measured. Associations were evaluated using Spearman correlation in the total cohort and stratified by cluster of differentiation 4 (CD4) count (&lt;350, 350\u2013500, &gt;500 cells\/\u03bcL) and disease duration (\u226424, 24\u201348, &gt;48 months). In the total cohort (n\u2005=\u200550 with lipid data), neither I-FABP (rs\u2005=\u2005\u22120.044,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.762) nor REG3\u03b1 (rs\u2005=\u20050.232,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.105) showed a significant correlation with LDL-C. However, in patients with CD4\u2005&lt;\u2005350 cells\/\u03bcL (n\u2005=\u200512), REG3\u03b1 demonstrated a strong positive correlation with LDL-C (rs\u2005=\u20050.643,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.024). This association was absent in patients with higher CD4 counts (350\u2013500: rs\u2005=\u20050.393,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.383; &gt;500: rs\u2005=\u20050.003,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.985). No significant associations were observed across disease duration strata. REG3\u03b1 correlates with LDL-C specifically in immunocompromised HIV patients (CD4\u2005&lt;\u2005350 cells\/\u03bcL), suggesting that gut barrier dysfunction may influence lipid metabolism preferentially in advanced HIV disease. This finding warrants further investigation regarding cardiovascular risk stratification in this vulnerable population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050244","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:02:42Z","timestamp":1786730562000},"page":"e50244","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between gut epithelial barrier biomarkers and LDL-cholesterol in HIV-infected individuals"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-3536","authenticated-orcid":false,"given":"Guliz","family":"Evik","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Etimesgut \u015eehit Sait Ert\u00fcrk State Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-2642","authenticated-orcid":false,"given":"Mete","family":"Ucdal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Etimesgut \u015eehit Sait Ert\u00fcrk State Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-3586","authenticated-orcid":false,"given":"Gulden","family":"Ersoz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Mersin University, Mersin, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"e20790","DOI":"10.1016\/j.heliyon.2023.e20790","article-title":"Severe intestinal barrier damage in HIV-infected immunological non-responders.","volume":"9","author":"Guo","year":"2023","journal-title":"Heliyon"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"1621765","DOI":"10.3389\/fmed.2025.1621765","article-title":"Persistent inflammatory activation in people living with HIV. Involvement in atherosclerosis.","volume":"12","author":"Illanes-\u00c1lvarez","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12664-025-01796-2","article-title":"Role of intestinal fatty acid binding protein in the non-invasive diagnosis of celiac disease in children.","volume":"45","author":"Kaul","year":"2025","journal-title":"Indian J Gastroenterol"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/infdis\/jiz423","article-title":"Plasma levels of C-type lectin REG3\u03b1 and gut damage in people with human immunodeficiency virus.","volume":"221","author":"Isnard","year":"2020","journal-title":"J Infect Dis"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2023.04.050","article-title":"Dyslipidemia in human immunodeficiency virus disease: JACC review topic of the week.","volume":"82","author":"Kalra","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"1173956","DOI":"10.3389\/fimmu.2023.1173956","article-title":"Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV.","volume":"14","author":"Ouyang","year":"2023","journal-title":"Front Immunol"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3390\/microorganisms12112221","article-title":"Gut microbiome alteration in HIV\/AIDS and the role of antiretroviral therapy \u2013 a scoping review.","volume":"12","author":"G\u00e1sp\u00e1r","year":"2024","journal-title":"Microorganisms"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12986-016-0089-7","article-title":"The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity.","volume":"13","author":"Lau","year":"2016","journal-title":"Nutr Metab (Lond)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:23Z","timestamp":1786982483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":8,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050244","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2025-12-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}